BostonGene Receives Frost & Sullivan's 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation
SAN ANTONIO , July 22, 2025 /CNW/ -- Frost & Sullivan has named BostonGene the recipient of the 2025 North American Enabling Technology Leadership Award in recognition of the company's pioneering role in advancing precision oncology. BostonGene's clinically validated, AI-powered platform uses a multimodal approach to decode disease and uncover predictive biological signatures.
BostonGene combines data from genes, RNA, proteins, the immune system and the tumor environment to help pharma and biotech develop targeted therapies, design efficient trials, and improve outcomes. Its "Comprehensive Digital Patient" model enables precise drug targeting, biomarker validation and patient stratification. With high test success and fast turnaround, BostonGene accelerates data-driven clinical decisions.
"BostonGene has developed state-of-the-art AI-driven, next-generation analytics technologies and is the only known source capable of delivering such comprehensive and integrated analyses," said Unmesh Lal , Healthcare Research Director at Frost & Sullivan. "What truly differentiates BostonGene is its ability to turn vast, complex datasets into clinically meaningful insights with speed and accuracy—delivering real impact not just in research settings but in real-world clinical and drug development environments where timely, actionable data is critical."
Backed by a decade of scientific investment and a growing intellectual property portfolio, BostonGene's capabilities span internal lab services, advanced analytics and multimodal assay integration. Its CLIA-certified, CAP-accredited and NYS-approved regulatory infrastructure ensures quality and compliance across global partnerships.
"By delivering tailored solutions, accelerating project timelines and driving innovation through advanced analytics, BostonGene is fundamentally transforming oncology drug development," said Manuel Albornoz , Best Practices Research Analyst at Frost & Sullivan. "Its adaptability, speed and scientific rigor make it a trusted partner for the industry."
"This recognition reinforces our commitment to equipping drug developers with the tools they need to make smarter, faster decisions," said Nathan Fowler , MD, Chief Medical Officer at BostonGene. "By integrating multiomic data and modeling the tumor microenvironment, we help our partners optimize trial design, improve patient selection and accelerate the development of targeted therapies."
Each year, Frost & Sullivan presents this award to a company that has developed a breakthrough technology with the potential to significantly enhance existing products and enable the creation of new solutions and applications. The award highlights technologies with strong potential for market adoption and industry impact.
Frost & Sullivan Best Practices Awards honor companies across regional and global markets that demonstrate excellence in innovation, leadership, customer service and strategic product development. Recipients are selected through a rigorous evaluation process involving in-depth interviews, market analysis and extensive secondary research to identify companies that set the benchmark for industry best practices.
Read the final report here.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion .
Contact:
Ashley Shreve
Marketing Coordinator - Best Practices Recognition
[email protected]
Phone: +1.210.844.2505
About BostonGene Corporation
BostonGene helps drug developers de-risk and accelerate research and development using a clinically validated AI platform purpose-built for oncology and supported by a CLIA-certified and CAP-accredited clinical laboratory. By integrating advanced molecular and immune profiling with clinical data, we uncover actionable insights that inform trial design, optimize patient selection and improve clinical outcomes. Our diagnostic and treatment recommendation solutions are used in clinical settings to personalize care and guide therapy decisions for patients. For more information, visit www.BostonGene.com .For more information, visit www.BostonGene.com .
Contact:
Erin Keleher
[email protected]
Phone: +1-617-283-2285
SOURCE Frost & Sullivan
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
13 hours ago
- Cision Canada
AVer Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Medical-Grade PTZ Cameras
Recognized for its AI-driven innovation, platform-agnostic product design, and exceptional customer-centric healthcare video solutions SAN ANTONIO, July 23, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that AVer Information Inc. has received the 2025 Global Company of the Year Recognition in the medical-grade PTZ cameras industry for its outstanding achievements in technology innovation, healthcare-focused strategy execution, and customer impact. This recognition highlights AVer's consistent leadership in driving measurable outcomes, strengthening its market position, and delivering customer-centric innovation in an evolving competitive landscape. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. AVer excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with efficiency, consistency, and scale. "AVer is right in the middle of a significant transformation in healthcare delivery, with products and services that enable and positively contribute to this change," said David Frigstad, Chairman at Frost & Sullivan. Guided by a long-term growth strategy focused on AI-driven innovation, platform-agnostic product design, and healthcare collaboration, AVer has shown its ability to adapt and lead in a rapidly evolving landscape. The company's strategic agility and sustained investment in connected healthcare solutions have enabled it to scale effectively across clinical and homecare environments. Innovation remains central to AVer's approach. Its suite of medical-grade PTZ cameras addresses the full spectrum of telehealth, tele-ICU, tele-sitting, and remote patient monitoring needs, offering seamless integration, scalability, and high-performance video capabilities. "We are thrilled to receive this prestigious award from Frost & Sullivan, one of the leading research firms in the healthcare industry," said Andy Hsi, CEO, AVer Information Inc. "AVer as a company is committed to making a positive difference in the revolutionary telehealth industry, empower smart healthcare environments and help create better patient outcomes for caregivers with our AI and video innovations." AVer's unwavering commitment to customer experience further strengthens its position in the market. By offering robust support resources—such as training videos, comprehensive manuals, and localized expert assistance via phone, email, or video conferencing—the company ensures that every implementation is successful. Its platform-agnostic camera designs simplify deployments across diverse healthcare settings, enhancing adoption and long-term value. Frost & Sullivan commends AVer for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, innovation pipeline, and customer-first culture are shaping the future of connected healthcare and driving tangible results at scale. Each year, Frost & Sullivan presents the Company of the Year Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. It recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices recognitions honor companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: E: [email protected] About AVer Information Inc. Founded in 2008, AVer is an award-winning provider of education technology, healthcare and video collaboration camera solutions that improve productivity and enrich learning. From accelerating learning in the classroom, safely supporting patient care, to increasing competitive advantage for businesses, AVer solutions leverage the power of technology to help people connect with one another to achieve great things. Our product portfolio includes Professional Grade Artificial Intelligence Enabled Auto Tracking Cameras, Medical Grade PTZ Cameras, Zoom and Microsoft Teams Certified Enterprise Grade USB Cameras, Document Cameras and Classroom Audio Solutions. We strive to provide industry leading service and support that exceeds our customer's expectations. We are also deeply committed to our community, the environment and employ stringent green processes in all we do.
Cision Canada
a day ago
- Cision Canada
Fiera Capital Announces June 30, 2025 Preliminary Assets Under Management and Q2 2025 Financial Results Date Français
MONTREAL, July 22, 2025 /CNW/ - Fiera Capital Corporation (TSX: FSZ) ("Fiera Capital" or the "Company"), a leading independent asset management firm, today announced its preliminary estimate of assets under management ("AUM") of approximately C$160.5 billion as at June 30, 2025, compared to C$161.6 billion as at March 31, 2025. Totals may not reconcile due to rounding. By Investment Platform AUM as at Quarter-over-Quarter Change Year-over-Year Change (in C$ billions) June 30, 2025 March 31, 2025 June 30, 2024 (in $B) % (in $B) % Public Markets AUM, excluding PineStone 103.8 104.1 96.5 -0.3 -0.2 % 7.3 7.5 % Public Markets AUM sub-advised by PineStone 35.8 36.4 43.2 -0.6 -1.5 % -7.4 -17.1 % Public Markets - Total 139.6 140.4 139.7 -0.8 -0.6 % -0.1 -0.1 % Private Markets 20.9 21.1 19.1 -0.3 -1.4 % 1.7 8.9 % Total AUM 160.5 161.6 158.9 -1.1 -0.7 % 1.6 1.0 % Totals may not reconcile due to rounding. Total AUM was down quarter over quarter reflecting the previously announced wind down of the Company's Canadian Equity Small and Micro Cap strategies. Excluding these strategies, AUM was flat as gains from equity market performance were offset by unfavourable foreign exchange impact from a weaker U.S. dollar, and new mandates in Equity strategies and Private Markets in the quarter were offset by negative net contributions in Fixed Income. Public Markets AUM, excluding AUM sub-advised by PineStone Asset Management Inc. ("PineStone") and excluding AUM related to wind down of the Canadian Equity Small and Micro Cap strategies, increased approximately 0.8% in the quarter. Growth was primarily driven by higher equity markets, partly offset by unfavourable foreign exchange impact and net outflows of approximately $450 million, mainly out of lower-fee Fixed Income strategies. Private Markets AUM decreased slightly in the quarter, due to unfavourable foreign exchange impact and return of capital to investors. Q2 2025 Results The Company will issue its financial results for the second quarter of 2025 on Friday, August 8, 2025, before markets open. A conference call will follow at 10:00 a.m. (ET) the same day. Conference Call Information: The conference call will be held on Friday, August 8, 2025, at 10:00 a.m. (ET). Financial analysts will be invited to ask questions. Media representatives and other interested individuals are invited to participate on a "listen-only" basis. Conference Call Access: To join the conference call without operator assistance, you may register and enter your phone number here to receive an instant automated call back. You can also dial direct to be entered into the call by an operator: From Canada and the United States: 1-800-990-4777 (toll free) Outside North America: 1-289-819-1299 The conference will also be accessible live via webcast. Financial Information: The earnings press release, supplementary financial information and a presentation will be posted on prior to the beginning of the conference call. Conference Call Replay: An audio replay of the call will be available until August 15, 2025, by dialling 1-888-660-6345 (North American toll free), access code 49008 followed by the number sign (#). The webcast will remain available for three months following the call and can be accessed on the Investor Relations section of Fiera Capital's website under Events and Presentations. Forward-Looking Statements This document contains forward-looking statements relating to future events or, future performance reflecting management's expectations or beliefs regarding future events, including, without limitation, business and economic conditions, outlook and trends, Fiera Capital's growth, results of operations, performance, business prospects and opportunities, objectives, plans and strategic priorities, new initiatives, such as those related to sustainability and other statements that do not refer to historical facts. Forward-looking statements may include comments on Fiera Capital's objectives, strategies to achieve these objectives, expected financial results or dividends, and the outlook for the Company's businesses, as well as for the Canadian, American, European, Asian and other global economies. Such forward-looking statements reflect management's current beliefs and are based on factors and assumptions it considers to be reasonable based on information currently available to management. These forward-looking statements may typically be identified by words and expressions such as "assumption, "continue", "estimate", "forecast", "goal", "guidance", "likely", "plan", "objective", "outlook", "potential", "foresee", "project", "strategy", "target", and other similar words or expressions or future or conditional verbs (including in their negative form), such as "aim", "anticipate", "believe", "could", "expect", "foresee", "intend", "may", "plan", "predict", "seek", "should", "strive" and "would". Forward-looking statements, by their very nature, are subject to inherent risks and uncertainties and are based on several assumptions, which make it possible for actual results or events to differ materially from management's expectations and that predictions, forecasts, projections, expectations, conclusions or statements will not prove to be accurate. As a result, the Company does not guarantee that any forward-looking statement will materialize and readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are presented for the purpose of assisting investors and others in understanding certain key elements of the Company's objectives, strategies, expectations, plans and business outlook as well as the anticipated operating environment. Readers are cautioned, however, that such information may not be appropriate for other purposes. A number of important risk factors and uncertainties, many of which are beyond Fiera Capital's control, could cause actual events, performance or results to differ materially from the predictions, forecasts, projections, expectations, conclusions or statements expressed in such forward-looking statements which include, without limitation: risks related to investment performance, investment of the assets under management ("AUM") including, without limitation, risks related to external market and economic conditions and other events beyond Fiera Capital's control such as the imposition of economic measures such as tariffs and other trade restrictions, AUM concentration related to strategies sub-advised by PineStone, key employees, asset management industry and competitive pressure, reputational risk, regulatory compliance, information security policies, procedures and capabilities, litigation risk, employee misconduct or error, insurance coverage, third-party relationships, client commitment, indebtedness, market risk, credit risk, inflation, interest rates and recession risks, ownership structure and potential dilution and other risks and uncertainties described in the Company's Annual Information Form for the year ended December 31, 2024 under the heading " Risk Factors and Uncertainties" or discussed in other materials filed by the Company with applicable securities regulatory authorities from time to time which are available on SEDAR+ at Readers are cautioned that the preceding list of risk factors and uncertainties is not exhaustive and that other risks and uncertainties could affect the Company. Additional risks and uncertainties, including those not currently known to Fiera Capital or currently deemed immaterial, could also have a material adverse effect on the Company's business, financial condition, liquidity, operations or financial results. When relying on forward-looking statements in this document or in any other disclosure made by Fiera Capital, investors and others should carefully consider the risks and uncertainties listed above, along with other potential events that could affect the Company's financial condition, operations, performance or results. Unless otherwise indicated, forward-looking statements in this press release describe management's expectations as at the date hereof and, accordingly, are subject to change after that date. Fiera Capital does not undertake to update or revise any forward-looking statement, whether written or oral, that may be made from time to time by it or on its behalf in order to reflect new information, future events or circumstances or otherwise, except as required by applicable law. About Fiera Capital Corporation Fiera Capital is a leading independent asset management firm with a growing global presence. The Company delivers customized and multi-asset solutions across public and private market asset classes to institutional, financial intermediary and private wealth clients across North America, Europe and key markets in Asia and the Middle East. Fiera Capital's depth of expertise, diversified investment platform and commitment to delivering outstanding service are core to our mission of being at the forefront of investment management science to create sustainable wealth for clients. Fiera Capital trades under the ticker FSZ on the Toronto Stock Exchange. Headquartered in Montreal, Fiera Capital, with its affiliates in various jurisdictions, has offices in over a dozen cities around the world, including New York (U.S.), London (UK), Hong Kong (SAR) and Abu Dhabi (ADGM). Each affiliated entity (each an "Affiliate") of Fiera Capital only provides investment advisory or investment management services or offers investment funds in the jurisdictions where the Affiliate is authorized to provide services pursuant to the relevant registrations, an exemption from such registrations and/or the relevant product is registered or exempt from registration. Fiera Capital does not provide investment advice to U.S. clients or offer investment advisory services in the U.S. In the U.S., asset management services are provided by Fiera Capital's Affiliates who are investment advisers that are registered with the U.S. Securities and Exchange Commission (SEC) or exempt from registration. Registration with the SEC does not imply a certain level of skill or training. For details on the particular registration of, or exemptions therefrom relied upon by, any Fiera Capital entity, please consult Disclosure The information presented is for informational purposes only and is not intended to be, and should not be construed as, an offer to sell, or the solicitation of an offer to buy, any investment product. The information presented in this document, in whole or in part, is not investment, tax, legal or other advice, nor does it consider the investment objectives or financial circumstances of any investor. SOURCE Fiera Capital Corporation
Cision Canada
a day ago
- Cision Canada
3CLogic and ScreenMeet Expand Partnership to Elevate ServiceNow-Powered Customer and IT Support with Voice AI and Rich Video Collaboration
Latest partnership helps leading Managed Services Provider, Solugenix, deliver smarter experiences powered by AI, Voice, and remote support to their restaurant franchise customers. ROCKVILLE, Md., July 22, 2025 /CNW/ -- 3CLogic, the leading AI-powered contact center platform purpose-built for ServiceNow®, and ScreenMeet, the only ServiceNow native provider of AI and video-based remote support, today announced the expansion of their strategic partnership. The collaboration between both ServiceNow-certified Build partners will focus on delivering unified Voice AI and Video experiences across both IT, HR, and Customer Support for enterprises leveraging the Now Platform. Per a recent Gartner 1 report, as GenAI continues to evolve, enterprises will likely shift from traditional multichannel to seamless multimodal experiences—placing voice and video at the core. By embedding advanced Voice AI self-service, enterprise-grade contact center capabilities, and rich video collaboration directly into the ServiceNow platform, 3CLogic and ScreenMeet empower IT Support Managers, Contact Center Directors and Customer Experience leaders to resolve incidents faster, reduce frustration, and drive higher satisfaction. "Our customers demand a single pane of glass for all support interactions," explains Denis Seynhaeve, CEO of 3CLogic. "By pairing our Voice AI and Contact Center platform with ScreenMeet's video collaboration, we're turning ServiceNow into the ultimate support hub—helping enterprises delight customers and slash resolution times." Key benefits of the 3CLogic + ScreenMeet collaboration for ServiceNow: Unified Voice AI, Intelligent Routing & Rich Video Collaboration – 3CLogic and ScreenMeet together transform ServiceNow into an end‑to‑end support hub by embedding Voice AI bots, self‑service automation, and advanced IVR routing alongside in‑context video, co‑browsing, and screen‑share. Routine inquiries are handled by AI with seamless hand‑offs to live agents routed to the right skill group, while ScreenMeet's video tools let agents see exactly what users see, whether troubleshooting a POS failure or guiding through software setup. Seamless Integration with ServiceNow Workflows – Both 3CLogic and ScreenMeet integrate with ServiceNow, leveraging the platform's AI capabilities and existing digital channels. This ensures that voice- and video-driven interactions automatically trigger ServiceNow tasks, updates, and analytics – delivering end-to-end traceability and insight. Agent Automation & Optimization – By combining 3CLogic's automated call recordings, real‑time call transcriptions, and GenAI‑powered call summarizations – each auto‑associated with the correct ServiceNow record – with ScreenMeet's AI summarization of video chat and screen‑share sessions, agents no longer spend time jotting notes or hunting down recordings. Together, 3CLogic and ScreenMeet populate agent work notes and update record (e.g., Incident, Case, etc.) histories automatically, freeing support teams to focus on complex issues rather than manual documentation. Enhanced Reporting & Insights – 3CLogic feeds real‑time contact‑center metrics – call volumes, queue health, sentiment scores – directly into ServiceNow dashboards, while ScreenMeet captures and stores session data, system info, recordings, and AI‑generated summaries in‑platform. This unified data model delivers consolidated wallboards and reports, giving managers a holistic view of voice and video interactions and actionable insights to continuously refine workflows and drive performance Real-World Use Case "By using 3CLogic and ScreenMeet together, we look forward to seamlessly routing every support request into a single, unified flow, instantly connecting customers with agents and launching live video sessions without any channel hopping," explains Chris Antonelli, EVP at Solugenix, a leading managed services provider catering to the world's largest restaurant franchises. "The joint solution lets our team see exactly what the customer sees, guide them step by step, and resolve issues faster – all within ServiceNow for a truly effortless support experience." "Video chat dramatically shrinks the time to resolution," adds Lou Guercia, COO of ScreenMeet. "When an agent can see the exact device, screen, or environment, they eliminate lengthy back-and-forth. Together with 3CLogic on ServiceNow, we deliver a unified experience that's fast, efficient, and secure." Availability and Next Steps The combined 3CLogic + ScreenMeet integration is generally available today. Enterprise organizations running ServiceNow IT Service Management, CRM and Industry Workflows, or Employee Service Center can engage their ServiceNow account teams or visit the 3CLogic and ScreenMeet websites to learn more. In addition 3CLogic and ScreenMeet will be sponsors and attend a number of the upcoming ServiceNow Fall events including the ServiceNow AI Summits in Atlanta and Dallas as well as the World Forum events in New York, Chicago, Munich, London, and Amsterdam. About 3CLogic 3CLogic transforms customer and employee experiences with its patented and award-winning AI-powered cloud contact center solutions purpose-built to enhance today's leading CRM and Customer Service Management platforms. Globally available and leveraged by the world's leading brands, its offerings empower enterprise organizations with innovative capabilities, such as intelligent self-service, Generative AI, Conversational AI, agent automation & coaching, and AI-powered sentiment analytics — all designed to lower operational costs, maximize ROI, and deliver better, faster, and more personalized interactions for IT, employee, and customer service. For more information, please visit About ScreenMeet ScreenMeet is a cloud‑native remote support and collaboration platform. Designed to embed seamlessly into leading CRM, AEM and ITSM systems – like ServiceNow, Tanium and Salesforce – ScreenMeet empowers enterprises with in‑browser voice, video, co‑browsing, and remote takeover capabilities, eliminating downloads and manual workflows. Trusted by over 50,000 agents and 400 million end users worldwide, ScreenMeet delivers secure, AI‑enhanced support experiences that modernize contact centers and IT help desks for the digital era. For more information please visit
